GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blueprint Medicines Corp (LTS:0HOJ) » Definitions » E10

Blueprint Medicines (LTS:0HOJ) E10 : $-5.32 (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Blueprint Medicines E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Blueprint Medicines's adjusted earnings per share data for the three months ended in Dec. 2024 was $-0.790. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.32 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-13), Blueprint Medicines's current stock price is $89.80. Blueprint Medicines's E10 for the quarter that ended in Dec. 2024 was $-5.32. Blueprint Medicines's Shiller PE Ratio of today is .


Blueprint Medicines E10 Historical Data

The historical data trend for Blueprint Medicines's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueprint Medicines E10 Chart

Blueprint Medicines Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -5.52 -5.32

Blueprint Medicines Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.52 -5.41 -5.35 -5.35 -5.32

Competitive Comparison of Blueprint Medicines's E10

For the Biotechnology subindustry, Blueprint Medicines's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueprint Medicines's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Blueprint Medicines's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Blueprint Medicines's Shiller PE Ratio falls into.



Blueprint Medicines E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Blueprint Medicines's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.79/133.1571*133.1571
=-0.790

Current CPI (Dec. 2024) = 133.1571.

Blueprint Medicines Quarterly Data

per share eps CPI Adj_EPS
201503 -0.556 99.621 -0.743
201506 -0.810 100.684 -1.071
201509 -0.470 100.392 -0.623
201512 -0.580 99.792 -0.774
201603 -0.570 100.470 -0.755
201606 -0.700 101.688 -0.917
201609 -0.620 101.861 -0.810
201612 -0.750 101.863 -0.980
201703 -0.840 102.862 -1.087
201706 -0.860 103.349 -1.108
201709 -0.960 104.136 -1.228
201712 -1.230 104.011 -1.575
201803 -1.290 105.290 -1.631
201806 -0.620 106.317 -0.777
201809 -1.660 106.507 -2.075
201812 -1.830 105.998 -2.299
201903 -1.980 107.251 -2.458
201906 -2.040 108.070 -2.514
201909 -1.930 108.329 -2.372
201912 -1.350 108.420 -1.658
202003 -2.110 108.902 -2.580
202006 -2.280 108.767 -2.791
202009 11.160 109.815 13.532
202012 -1.530 109.897 -1.854
202103 -1.720 111.754 -2.049
202106 -1.860 114.631 -2.161
202109 -2.000 115.734 -2.301
202112 -5.400 117.630 -6.113
202203 -1.790 121.301 -1.965
202206 -2.680 125.017 -2.855
202209 -2.230 125.227 -2.371
202212 -2.650 125.222 -2.818
202303 -2.150 127.348 -2.248
202306 -2.190 128.729 -2.265
202309 -2.200 129.860 -2.256
202312 -1.820 129.419 -1.873
202403 1.400 131.776 1.415
202406 -0.800 132.554 -0.804
202409 -0.890 133.029 -0.891
202412 -0.790 133.157 -0.790

Add all the adjusted EPS together and divide 10 will get our e10.


Blueprint Medicines  (LTS:0HOJ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Blueprint Medicines E10 Related Terms

Thank you for viewing the detailed overview of Blueprint Medicines's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueprint Medicines Business Description

Traded in Other Exchanges
Address
45 Sidney Street, Cambridge, MA, USA, 02139
Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.

Blueprint Medicines Headlines

No Headlines